BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31135156)

  • 1. Glucopyranosylidene-spiro-benzo[ b][1,4]oxazinones and -benzo[ b][1,4]thiazinones: Synthesis and Investigation of Their Effects on Glycogen Phosphorylase and Plant Growth Inhibition.
    Kun S; Kánya N; Galó N; Páhi A; Mándi A; Kurtán T; Makleit P; Veres S; Sipos Á; Docsa T; Somsák L
    J Agric Food Chem; 2019 Jun; 67(24):6884-6891. PubMed ID: 31135156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucopyranosylidene-spiro-iminothiazolidinone, a new bicyclic ring system: synthesis, derivatization, and evaluation for inhibition of glycogen phosphorylase by enzyme kinetic and crystallographic methods.
    Czifrák K; Páhi A; Deák S; Kiss-Szikszai A; Kövér KE; Docsa T; Gergely P; Alexacou KM; Papakonstantinou M; Leonidas DD; Zographos SE; Chrysina ED; Somsák L
    Bioorg Med Chem; 2014 Aug; 22(15):4028-41. PubMed ID: 25009003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucopyranosylidene-spiro-imidazolinones, a New Ring System: Synthesis and Evaluation as Glycogen Phosphorylase Inhibitors by Enzyme Kinetics and X-ray Crystallography.
    Szabó KE; Kyriakis E; Psarra AG; Karra AG; Sipos Á; Docsa T; Stravodimos GA; Katsidou E; Skamnaki VT; Liggri PGV; Zographos SE; Mándi A; Király SB; Kurtán T; Leonidas DD; Somsák L
    J Med Chem; 2019 Jul; 62(13):6116-6136. PubMed ID: 31251604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of C-xylopyranosyl- and xylopyranosylidene-spiro-heterocycles as potential inhibitors of glycogen phosphorylase.
    Somsák L; Bokor É; Czibere B; Czifrák K; Koppány C; Kulcsár L; Kun S; Szilágyi E; Tóth M; Docsa T; Gergely P
    Carbohydr Res; 2014 Nov; 399():38-48. PubMed ID: 25081322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose-derived spiro-isoxazolines are anti-hyperglycemic agents against type 2 diabetes through glycogen phosphorylase inhibition.
    Goyard D; Kónya B; Chajistamatiou AS; Chrysina ED; Leroy J; Balzarin S; Tournier M; Tousch D; Petit P; Duret C; Maurel P; Somsák L; Docsa T; Gergely P; Praly JP; Azay-Milhau J; Vidal S
    Eur J Med Chem; 2016 Jan; 108():444-454. PubMed ID: 26708111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anomeric spirocycles by solvent incorporation: reactions of O-peracylated (glyculopyranose and glyculopyranosyl bromide)onamide derivatives with ketones.
    Páhi A; Czifrák K; Kövér KE; Somsák L
    Carbohydr Res; 2015 Feb; 403():192-201. PubMed ID: 24933234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New synthesis of 3-(β-D-glucopyranosyl)-5-substituted-1,2,4-triazoles, nanomolar inhibitors of glycogen phosphorylase.
    Kun S; Bokor É; Varga G; Szőcs B; Páhi A; Czifrák K; Tóth M; Juhász L; Docsa T; Gergely P; Somsák L
    Eur J Med Chem; 2014 Apr; 76():567-79. PubMed ID: 24608000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel design principle validated: glucopyranosylidene-spiro-oxathiazole as new nanomolar inhibitor of glycogen phosphorylase, potential antidiabetic agent.
    Somsák L; Nagy V; Vidal S; Czifrák K; Berzsényi E; Praly JP
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5680-3. PubMed ID: 18793852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-(2-Deoxy-d-arabino-hex-1-enopyranosyl)-oxadiazoles: synthesis of possible isomers and their evaluation as glycogen phosphorylase inhibitors.
    Bokor É; Szennyes E; Csupász T; Tóth N; Docsa T; Gergely P; Somsák L
    Carbohydr Res; 2015 Aug; 412():71-9. PubMed ID: 26082971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of C-β-d-glucopyranosyl derivatives of some fused azoles for the inhibition of glycogen phosphorylase.
    Szennyes E; Bokor É; Docsa T; Sipos Á; Somsák L
    Carbohydr Res; 2019 Jan; 472():33-41. PubMed ID: 30453096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-Glucopyranosyl-1,2,4-triazol-5-ones: synthesis and inhibition of glycogen phosphorylase.
    Bokor É; Széles Z; Docsa T; Gergely P; Somsák L
    Carbohydr Res; 2016 Jun; 429():128-34. PubMed ID: 26818133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose-based spiro-oxathiazoles as in vivo anti-hyperglycemic agents through glycogen phosphorylase inhibition.
    Goyard D; Kónya B; Czifrák K; Larini P; Demontrond F; Leroy J; Balzarin S; Tournier M; Tousch D; Petit P; Duret C; Maurel P; Docsa T; Gergely P; Somsák L; Praly JP; Azay-Milhau J; Vidal S
    Org Biomol Chem; 2020 Feb; 18(5):931-940. PubMed ID: 31922157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic, enzyme kinetic, and protein crystallographic studies of C-β-d-glucopyranosyl pyrroles and imidazoles reveal and explain low nanomolar inhibition of human liver glycogen phosphorylase.
    Kantsadi AL; Bokor É; Kun S; Stravodimos GA; Chatzileontiadou DSM; Leonidas DD; Juhász-Tóth É; Szakács A; Batta G; Docsa T; Gergely P; Somsák L
    Eur J Med Chem; 2016 Nov; 123():737-745. PubMed ID: 27522507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of N-glucopyranosidic derivatives as potential inhibitors that bind at the catalytic site of glycogen phosphorylase.
    Gimisis T
    Mini Rev Med Chem; 2010 Oct; 10(12):1127-38. PubMed ID: 20716054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of glycogen phosphorylase b: synthesis, biochemical screening, and molecular modeling studies of novel analogues of hydantocidin.
    Agasimundin YS; Mumper MW; Hosmane RS
    Bioorg Med Chem; 1998 Jul; 6(7):911-23. PubMed ID: 9730227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of 2-(β-D-glucopyranosyl)-5-(substituted-amino)-1,3,4-oxa- and -thiadiazoles for the inhibition of glycogen phosphorylase.
    Szőcs B; Tóth M; Docsa T; Gergely P; Somsák L
    Carbohydr Res; 2013 Nov; 381():187-95. PubMed ID: 23582340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of (benzimidazol-2-yl)aniline derivatives as glycogen phosphorylase inhibitors.
    Galal SA; Khattab M; Andreadaki F; Chrysina ED; Praly JP; Ragab FAF; El Diwani HI
    Bioorg Med Chem; 2016 Nov; 24(21):5423-5430. PubMed ID: 27624527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of and a comparative study on the inhibition of muscle and liver glycogen phosphorylases by epimeric pairs of d-gluco- and d-xylopyranosylidene-spiro-(thio)hydantoins and N-(d-glucopyranosyl) amides.
    Somsák L; Kovács L; Tóth M; Osz E; Szilágyi L; Györgydeák Z; Dinya Z; Docsa T; Tóth B; Gergely P
    J Med Chem; 2001 Aug; 44(17):2843-8. PubMed ID: 11495595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose analog inhibitors of glycogen phosphorylases as potential antidiabetic agents: recent developments.
    Somsák L; Nagya V; Hadady Z; Docsa T; Gergely P
    Curr Pharm Des; 2003; 9(15):1177-89. PubMed ID: 12769745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucopyranosylidene-Spiro-Thiazolinones: Synthetic Studies and Determination of Absolute Configuration by TDDFT-ECD Calculations.
    Szabó KE; Kun S; Mándi A; Kurtán T; Somsák L
    Molecules; 2017 Oct; 22(10):. PubMed ID: 29048398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.